Systemic use of tumor necrosis factor alpha as an anticancer agent

by Roberts, Nicholas J., Zhou, Shibin, Diaz, Luis A., Holdhoff, Matthias
Published 2011

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

by Messmer, Marcus, Upreti, Sunita, Tarabishy, Yaman, Mazumder, Nikhilesh, Chowdhury, Reezwana, Yarchoan, Mark, Holdhoff, Matthias
Published 2016

A Robust Approach to Enhance Tumor-selective Accumulation of Nanoparticles

by Qiao, Yuan, Huang, Xin, Nimmagadda, Sridhar, Bai, Renyuan, Staedtke, Verena, Foss, Catherine A., Cheong, Ian, Holdhoff, Matthias, Kato, Yoshinori, Pomper, Martin G., Riggins, Gregory J., Kinzler, Kenneth W., Diaz, Luis A., Vogelstein, Bert, Zhou, Shibin
Published 2011

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced canc...

by Rodón, Jordi, Carducci, Michael, Sepulveda-Sánchez, Juan M., Azaro, Analía, Calvo, Emiliano, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Gueorguieva, Ivelina, Cleverly, Ann, Pillay, N. Sokalingum, Desaiah, Durisala, Estrem, Shawn T., Paz-Ares, Luis, Holdhoff, Matthias, Blakeley, Jaishri, Lahn, Michael M., Baselga, Jose
Published 2014

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

by Jiao, Yuchen, Killela, Patrick J., Reitman, Zachary J., Rasheed, B. Ahmed, Heaphy, Christopher M., de Wilde, Roeland F., Rodriguez, Fausto J., Rosemberg, Sergio, Oba-Shinjo, Sueli Mieko, Marie, Suely Kazue Nagahashi, Bettegowda, Chetan, Agrawal, Nishant, Lipp, Eric, Pirozzi, Christopher J., Lopez, Giselle Y., He, Yiping, Friedman, Henry S., Friedman, Allan H., Riggins, Gregory J., Holdhoff, Matthias, Burger, Peter, McLendon, Roger E., Bigner, Darell D., Vogelstein, Bert, Meeker, Alan K., Kinzler, Kenneth W., Papadopoulos, Nickolas, Diaz, Luis A., Yan, Hai
Published 2012